US 10494401
LLP2A-bisphosphonate conjugates for osteoporosis treatment
granted A61KA61K31/00A61K31/66
Quick answer
US patent 10494401 (LLP2A-bisphosphonate conjugates for osteoporosis treatment) held by The Regents of the University of California expires Mon Nov 28 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Regents of the University of California
- Grant date
- Tue Dec 03 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Nov 28 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 19
- CPC classes
- A61K, A61K31/00, A61K31/66, A61K31/661, A61K31/663